Good Lifestyle

The rapid renown of Ozempic is undeniable: since the drug against diabetes began to be prescribed out of AMM for weight loss, it has become synonymous with a new class of drugs to lose weight quickly. Along the way, Ozempic has courted the controversy, thanks to well -documented documents Side effects And one shortage continues This has put some diabetic patients in danger. Its success has also led to other drug manufacturers accelerating their weight loss efforts, with a multitude of similar drugs on the market or on their way. And according to new research, the first competitor of Ozempic Mounjaro can actually be more effective. Read the rest to find out more about the latest discoveries.

In relation: The new ozempic competitor for weight loss can be better tolerated .

If you are looking to lose weight using medical intervention, you certainly have options. Although Ozempic has become the best known, there are currently three other similar injects in the process of making waves: Wegovy, Mounjaro and Zepbound. Wegovy is the the most similar In Ozempic, because they both use the semaglutide to stimulate the GLP-1 receiver and ensure that users are less hungry, according to Healthline. AE0FCC31AE342FD3A1346EBB1F342FCB

Wegovy and Ozempic are both made by Novo Nordisk, but only the former were approved for weight loss. Mounjaro and Zepbound, on the other hand, come from the company Eli Lilly and contain Tirzepatide, reports Healthline. Tirzepatid drugs help users lose weight by imitating two Hunger regulatory hormones: GLP-1 and GIP.

Similar to Ozempic and Wegovy, Mounjaro is prescribed out of AMM for weight loss, while Zepbound has just become official Food and Drug Administration (FDA) Weight management approval. But a recent study has put Ozempic and Mounjaro on-one to measure their effectiveness-and the results can be surprising.

In relation: Certain foods trigger the weight loss effect of the natural ozempic type, says the doctor .

A new study carried out by Trontata Research was published on November 22 as a Pre -printed on medrxiv , and has not yet been evaluated by peers. The researchers examined health care data on approximately 18,000 overweight or obese adults and began to take Ozempic or Mounjaro between May 2022 and seven. 2023.

The objective of research was "to compare weight loss on treatment in a real frame for overweight adults or obesity initiated on shooting or semaglutide". In other words, the study sought to discover how these often prescribed drugs really work when it comes to losing weight.

In relation: The new drug has people who lose 60 pounds on average, shows research - and it's not ozempic .

The results of the study were clear: Mounjaro surpassed the Ozempic in each turn. After a year of treatment, the researchers found that patients taking Mounjaro lost an average of 15.2% of their body weight, while those using Ozempic lost an average of 7.9% in the same period of time.

Overall, Mounjaro users were three times more likely than those who took Ozempic to reach weight loss of 15% or more. They were also 2.6 times more likely to lose 10% of their weight than those of the Ozempic, and 1.8 times more likely to lose 5% of their weight, according to the study.

"In this great analysis of the real world, paired by the propensity, overweight people or the obesity treated with shooting were significantly more likely to achieve clinically significant weight loss and greater reductions in body weight compared to Those treated with semaglutide, "concluded the researchers.

These results correspond to what doctors see in their patients, Caroline Messer , MD, endocrinologist at Lenox Hill Hospital in Northwell Health in New York, recently Tell Healthline .

"It's almost double weight loss in most of my patients [with shooting]," she told the media. "So, certainly the shooting is more effective."

Many experts believe that its advantage comes from the operation of the shooting compared to the semaglutide.

"Due to its double hormone mechanism, Mounjaro seems to provide a greater improvement in glucose control than the Ozempic", " Christopher McGowan , gastroenterologist, specialist in obesity medicine, and founder of the weight loss of True You, Tell Healthline .

But for many patients, the drug to choose often comes down to the cost. And if you do not have type 2 diabetes, you will have to find a doctor to prescribe Ozempic and Mounjaro outside AMM, which means that it will certainly not be covered by health insurance.

More efficient or not, Mounjaro is on average More expensive option In the United States, in the United States, Mounjaro's monthly costs are about $ 1,023 without insurance, while the monthly cost of the Ozempic without insurance is $ 936, according to the Health .

In relation: For more information, register for our daily newsletter .

Best Life offers the most up -to -date information for high -level experts, new research and health agencies, but our content is not supposed to replace professional advice. Regarding the medication you take or any other health issue you have, always consult your health care provider directly.